Determination of the molecular basis of Marfan syndrome: a growth industry

AUTOR(ES)

Byers, Peter H.

FONTE

American Society for Clinical Investigation

RESUMO

Although it has been known for more than a decade that Marfan syndrome — a dominantly inherited connective tissue disorder characterized by tall stature, arachnodactyly, lens subluxation, and a high risk of aortic aneurysm and dissection — results from mutations in the FBN1 gene, which encodes fibrillin-1, the precise mechanism by which the pleiotropic phenotype is produced has been unclear. A report in this issue now proposes that loss of fibrillin-1 protein by any of several mechanisms and the subsequent effect on the pool of TGF-β may be more relevant in the development of Marfan syndrome than mechanisms previously proposed in a dominant-negative disease model. The model proposed in this issue demonstrates several strategies for clinical intervention.

Documentos Relacionados

• Marfan syndrome: a mystery solved.
• Giant intracranial aneurysm associated with Marfan's syndrome: a case report.
• Marfan's syndrome: early and severe form in siblings
• Aortic root complications in Marfan's syndrome: identification of a lower risk group.
• Marfan syndrome: an update of genetics, medical and surgical management